More recently, mechanistic investigations have documented another ALKBH5-mediated inhibition of the most common form of pancreatic cancers, the pancreatic ductal adenocarcinoma, through the ALKBH5 dependent-Wnt inhibitory factor one pathway (Tang et al., 2020). This evidence concerns the gene ALKBH5 and familial pancreatic carcinoma.